Biomanufacturing for clinically advanced cell therapies
The achievements of cell-based therapeutics have galvanized efforts to bring cell therapies to the market. To address the demands of the clinical and eventual commercial-scale production of cells, and with the increasing generation of large clinical datasets from chimeric antigen receptor T-cell imm...
Main Authors: | Aijaz, Ayesha, Li, Matthew, Smith, David, Khong, Danika, LeBlon, Courtney, Olabisi, Ronke M., Libutti, Steven, Tischfield, Jay, Maus, Marcela V., Deans, Robert, Barcia, Rita N., Anderson, Daniel Griffith, Ritz, Jerome, Preti, Robert, Parekkadan, Biju, Fenton, Owen Shea |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2019
|
Online Access: | https://hdl.handle.net/1721.1/121979 |
Similar Items
-
Cellular and molecular immunotherapeutics derived from the bone marrow stroma
by: Parekkadan, Biju
Published: (2008) -
Biomanufacturing Automation Plug & Play
by: Mikkelson, Andrew
Published: (2022) -
An Investigation of Multivariate Process Control for Biomanufacturing
by: Lui, Christopher A.
Published: (2022) -
Revolutionizing standard operating procedures in biomanufacturing
by: Nag, Aditya
Published: (2013) -
The impact of SARS-COV-2 on biomanufacturing operations
by: Barone, Paul, et al.
Published: (2021)